The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Detection of Renal Function Decline in Patients with Diabetes and Normal or Elevated GFR by Serial Measurements of Serum Cystatin C Concentration: Results of a 4-Year Follow-Up Study
Open accessAbstract
Research on early renal function decline in diabetes is hampered by lack of simple tools for detecting trends (particularly systematic decreases) in renal function over time when GFR is normal or elevated. This study sought to assess how well serum cystatin C meets that need. Thirty participants with type 2 diabetes in the Diabetic Renal Disease Study met these three eligibility criteria: GFR >20 ml/min per 1.73 m2 at baseline (based on cold iothalamate clearance), 4 yr of follow-up, and yearly measurements of iothalamate clearance and serum cystatin C. With the use of linear regression, each individual's trend in renal function over time, expressed as annual percentage change in iothalamate clearance, was determined. Serum cystatin C in mg/L was transformed to its reciprocal (100/cystatin C), and linear regression was used to determine each individual's trend over time, expressed as annual percentage change. In paired comparisons of 100/cystatin C with iothalamate clearance at each examination, the two measures were numerically similar. More important, the trends in 100/cystatin C and iothalamate clearance were strongly correlated (Spearman r = 0.77). All 20 participants with negative trends in iothalamate clearance (declining renal function) also had negative trends for 100/cystatin C. Results were discordant for only three participants. In contrast, the trends for three commonly used creatinine-based estimates of GFR compared poorly with trends in iothalamate clearance (Spearman r < 0.35). Serial measures of serum cystatin C accurately detect trends in renal function in patients with normal or elevated GFR and provide means for studying early renal function decline in diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Self-citationSerum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis
Dharnidharka, V. R., Kwon, C., & Stevens, G. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34487 · Cited by 1,663
Longitudinal Studies on the Rate of Decline in Renal Function with Age
Lindeman, R. D., Tobin, J., & Shock, N. W. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb07117.x · Cited by 1,578
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
Knight, E. L., Verhave, J. C., Spiegelman, D., Hillege, H. L., De Zeeuw, D., Curhan, G. C., & De Jong, P. E. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00517.x · Cited by 1,039
Cystatin C: An Improved Estimator of Glomerular Filtration Rate?
Laterza, O. F., Price, C. P., & Scott, M. G. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.5.699 · Cited by 658
Hoek, F. J. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg349 · Cited by 564
Nelson, R. G., Bennett, P. H., Beck, G. J., Tan, M., Knowler, W. C., Mitch, W. E., Hirschman, G. H., & Myers, B. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611283352203 · Cited by 477
Self-citationCystatin C—A New Marker of Glomerular Filtration Rate in Children Independent of Age and Height
Bökenkamp, A., Domanetzki, M., Zinck, R., Schumann, G., Byrd, D., & Brodehl, J. (1998) · Pediatrics · doi:10.1542/peds.101.5.875 · Cited by 392
Serum Cystatin C as an Endogenous Marker of the Renal Function – a Review
Randers, E., & Erlandsen, E. J. (1999) · cclm · doi:10.1515/cclm.1999.064 · Cited by 334
Mussap, M., Vestra, M. D., Fioretto, P., Saller, A., Varagnolo, M., Nosadini, R., & Plebani, M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00253.x · Cited by 292
Wiseman, M. J., Saunders, A. J., Keen, H., & Viberti, G. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503073121004 · Cited by 266
Vinge, E., Lindergård, B., Nilsson–Ehle, P., & Grubb, A. (1999) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519950185076 · Cited by 265
How to assess glomerular function and damage in humans
Rahn, K. H., Heidenreich, S., & Brückner, D. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917030-00002 · Cited by 224
Newman, D. J. (2002) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/0004563021901847 · Cited by 215
Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency
Hsu, C.-Y., Chertow, G. M., & Curhan, G. C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00299.x · Cited by 196
Determination of Serum Cystatin C: Biological Variation and Reference Values
Galteau, M.-M., Guyon, M., Gueguen, R., & Siest, G. (2001) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2001.141 · Cited by 159
Tan, G. D., Lewis, A. V., James, T. J., Altmann, P., Taylor, R. P., & Lévy, J. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2004 · Cited by 154
Developments in the assessment of glomerular filtration rate
Price, C. P., & Finney, H. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00233-3 · Cited by 139
How to Protect the Kidney in Diabetic Patients: With Special Reference to IDDM
Mogensen, C. (1997) · Diabetes · doi:10.2337/diab.46.2.s104 · Cited by 120
Randers, E., Erlandsen, E. J., Pedersen, O. L., Hasling, C., & Danielsen, H. (2000) · PubMed · Cited by 115
Serum Cystatin C Reliably Detects Renal Dysfunction in Patients with Various Renal Diseases
Kazama, J. J., Kutsuwada, K., Ataka, K., Maruyama, H., & Gejyo, F. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000057599 · Cited by 102
Application of newer clearance techniques for the determination of glomerular filtration rate
Gaspari, F., Perico, N., & Remuzzi, G. (1998) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199811000-00009 · Cited by 93
Predictive Performance of Ten Equations for Estimating Creatinine Clearance in Cardiac Patients
Spinler, S. A., Nawarskas, J. J., Boyce, E. G., Connors, J. E., Charland, S. L., Goldfarb, S., & The Iohexol Cooperative Study Group (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.18122 · Cited by 93
Mussap, M., Ruzzante, N., Varagnolo, M., & Plebani, M. (1998) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1998.151 · Cited by 83
Progression of overt nephropathy in non-insulin-dependent diabetes
Myers, B. D., Nelson, R. G., Tan, M., Beck, G. J., Bennett, P. H., Knowler, W. C., Blouch, K. L., & Mitch, W. E. (1995) · Kidney International · doi:10.1038/ki.1995.246 · Cited by 66
Self-citationCommentary: Clinical diagnostic use of cystatin C
Massey, D. H. (2004) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.10098 · Cited by 60
Serum cystatin C as a marker of glomerular filtration rate
Dworkin, L. D. (2001) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200109000-00001 · Cited by 57
Comparative performance of serum cystatin-c versus serum creatinine in diabetic subjects
Buysschaert, M., Joudi, I., Wallemacq, P. E., & Hermans, M. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70048-4 · Cited by 23
Nair, K. S., Pabico, R. C., Truglia, J. A., et al. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.711 · Cited by 19
Cited by
Chronic Kidney Disease: Effects on the Cardiovascular System
Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448
Temporal trends in the prevalence of diabetic kidney disease in the United States
de Boer, I. H. (2011) · JAMA · doi:10.1001/jama.2011.861 · Cited by 1,036
“However, a number of studies demonstrated that impaired GFR can occur without substantial albuminuria and that DKD can manifest solely as impaired GFR.(37-41) Our study suggests that the clinical pattern of DKD may be shifting over time, with more impaired GFR and the possibility of decreased albuminuria, which could…”
BackgroundGlomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., van Bommel, E. J., Heerspink, H. J. L., van Raalte, D. H., & Joles, J. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060666 · Cited by 887
“…on the basis of serum cystatin C is suggested to more accurately re fl ect renal function in patients with diabetes and normal or elevated GFR. 17,18 Never-theless, renal clearance techniques using inulin, or its more widely used alternative sinistrin, are required for gold standard measurement…”
Shlipak, M. G., Katz, R., Sarnak, M. J., Fried, L. F., Newman, A. B., Stehman-Breen, C., Seliger, S. L., Kestenbaum, B., Psaty, B., Tracy, R. P., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00003 · Cited by 540
Markers of and Risk Factors for the Development and Progression of Diabetic Kidney Disease
MacIsaac, R. J., Ekinci, E. I., & Jerums, G. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.10.048 · Cited by 378
Metadata
- Authors
- Perkins, B. A., Nelson, R. G., Ostrander, B. E. P., Blouch, K. L., Krolewski, A. S., Myers, B. D., & Warram, J. H.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-05
- Volume
- 16
- Issue
- 5
- Pages
- 1404-1412
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2105258594
- Cited by
- 323
- References
- 32
- FWCI
- 18.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.